Citigroup downgraded shares of Oxford Nanopore Technologies (LON:ONT – Free Report) to a buy rating in a research report sent to investors on Monday morning,Digital Look reports.
Other research analysts also recently issued research reports about the stock. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a research note on Tuesday, May 26th. Berenberg Bank lowered their price objective on shares of Oxford Nanopore Technologies from GBX 230 to GBX 220 and set a “buy” rating for the company in a research report on Monday, July 13th. Finally, Peel Hunt reissued a “hold” rating and issued a GBX 153 price objective on shares of Oxford Nanopore Technologies in a research report on Monday, July 13th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Oxford Nanopore Technologies currently has an average rating of “Moderate Buy” and a consensus price target of GBX 212.60.
Check Out Our Latest Research Report on ONT
Oxford Nanopore Technologies Stock Down 2.6%
Insider Activity at Oxford Nanopore Technologies
In other news, insider Nick Keher purchased 22,018 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were purchased at an average price of GBX 113 per share, for a total transaction of £24,880.34. Insiders acquired a total of 22,774 shares of company stock worth $2,578,100 in the last 90 days. Company insiders own 2.54% of the company’s stock.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Further Reading
- Five stocks we like better than Oxford Nanopore Technologies
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
